Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Orthofix Medical (OFIX) Non-Current Deferred Tax Liability (2018 - 2025)

Orthofix Medical's Non-Current Deferred Tax Liability history spans 9 years, with the latest figure at $4.2 million for Q4 2025.

  • For the quarter ending Q4 2025, Non-Current Deferred Tax Liability rose 2.68% year-over-year to $4.2 million, compared with a TTM value of $4.2 million through Dec 2025, up 2.68%, and an annual FY2025 reading of $4.2 million, up 2.68% over the prior year.
  • Non-Current Deferred Tax Liability for Q4 2025 was $4.2 million at Orthofix Medical, up from $4.1 million in the prior quarter.
  • The five-year high for Non-Current Deferred Tax Liability was $4.2 million in Q4 2025, with the low at $2.1 million in Q4 2023.
  • Average Non-Current Deferred Tax Liability over 3 years is $3.5 million, with a median of $4.1 million recorded in 2024.
  • Year-over-year, Non-Current Deferred Tax Liability surged 96.12% in 2024 and then grew 2.68% in 2025.
  • Tracing OFIX's Non-Current Deferred Tax Liability over 3 years: stood at $2.1 million in 2023, then soared by 96.12% to $4.1 million in 2024, then rose by 2.68% to $4.2 million in 2025.
  • Per Business Quant, the three most recent readings for OFIX's Non-Current Deferred Tax Liability are $4.2 million (Q4 2025), $4.1 million (Q4 2024), and $2.1 million (Q4 2023).